ONC BeiGene: Bozor kapitallashuvining balans qiymatiga nisbati

BeiGene Ltd (ONC) - korporativ logo

Bozor qiymatining balans qiymatiga nisbati o'zgarishi aktivlar baholash dinamikasini namoyish etadi, bunda 8.07 darajasi joriy holatni aks ettiradi. BeiGene Ltd (ONC) o'zining asosiy dori vositasini global miqyosda targ'ib qilish orqali Xitoyga bo'lgan bog'liqligini kamaytirmoqda. AQSh va Xitoydagi yuqori texnologiyali zavodlar barqaror sifatni kafolatlaydi. Daromadlar global onkologiya markazlari va sug'urta fondlariga maqsadli terapiya yetkazib berish orqali shakllantirilmoqda.

BeiGene Oncology (ONC): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

BeiGene Ltd. (ONC) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi BeiGene Ltd|ONC - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi BeiGene Corp|ONC - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar BeiGene|ONC - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati beigene.com|ONC - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati BeiGene Ltd|ONC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati BeiGene Corp|ONC - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati BeiGene Corp
Kompaniyaning asosiy tahlili:ONC (BeiGene Ltd)
BeiGene Corp brendining mahsuloti

Ushbu koeffitsiyent barcha aksiyalarning bozor qiymati va sof aktivlar qiymati o'rtasidagi nisbat sifatida hisoblanadi hamda nomoddiy afzalliklar uchun premiumni va biznesning strategik salohiyatini belgilaydi. BeiGene Ltd (ONC) kompaniyasining AQSh va Yevropa bozorlariga kengayishi kontekstida, narxning buki qiymatiga nisbati tarixi yangi dori vositalari tasdiqlanishining monetizatsiyasiga bo'lgan investorlar ishonchini aks ettiradi va kelajakdagi o'sish uchun haddan tashqari ko'p to'lash xavfini baholash imkonini beradi.

Raqobatchilar tahlili

HALO (Halozyme Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|revmed.com (RVMD) - Kapitallashuvning sof aktivlarga nisbati|AAPG (Ascentage Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor qiymatining balans qiymatiga nisbati UroGen URGN|Kapitallashuvning balans qiymatiga nisbati Bicara Corp (BCAX)|Personalis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati erasca.com ERAS|DCTH (Delcath Systems) - Bozor kapitallashuvining balans qiymatiga nisbati|YMAB: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Aura Bio AURA|Balans qiymatiga nisbatan bozor qiymati Candel Therapeutics, Inc.|ARAY - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati SELLAS Life Sciences Group Inc.|Bozor kapitallashuvining balans qiymatiga nisbati ACTU (Actuate Therapeutics)|Kapitallashuvning sof aktivlarga nisbati Citius Oncology Inc. CTOR|Kapitallashuvning sof aktivlarga nisbati HURA (TuHURA Biosciences)|Protara Tx - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Fate Therapeutics, Inc. (FATE)|WHWK - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TCRX|Champions Oncology, Inc. (CSBR) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati XBiotech Inc|Bozor qiymatining balans qiymatiga nisbati CEL-SCI Corp|OS Therapies Incorporated - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Radiopharm Theranostics Ltd (RADX)|Bozor kapitallashuvining balans qiymatiga nisbati ARTV|Balans qiymatiga nisbatan bozor kapitallashuvi Adlai Nortye Ltd ANL|Bozor kapitallashuvining balans qiymatiga nisbati VERU|TPST - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati XLO|RENB (Renovaro) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Mural Oncology PLC (MURA)|Kapitallashuvning balans qiymatiga nisbati Kairos Pharma Inc|OnKure Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti w2.cytomed.sg GDTC|Kapitallashuvning sof aktivlarga nisbati Curis|Apollomics Inc. - Balans qiymatiga nisbatan bozor qiymati|THAR - Bozor qiymatining balans qiymatiga nisbati|Advanced Biomed Inc (ADVB) - Bozor qiymatining balans qiymatiga nisbati|GNPX - Kapitallashuvning sof aktivlarga nisbati|Calidi Biotherapeutics, Inc. (CLDI) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati Sunshine Biopharma (SBFM)|Kapitallashuvning balans qiymatiga nisbati XBIO|Salarius Pharmaceuticals, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti PPBT (Purple Biotech Ltd)|AONC - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati BeiGene Ltd BGNE|CKPT: Bozor kapitallashuvining balans qiymatiga nisbati|ELEV - Kapitallashuvning sof aktivlarga nisbati|ICAD (icadmed.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Ikena Oncology (IKNA) - Kapitallashuvning sof aktivlarga nisbati|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VIRX|Bozor qiymatining balans qiymatiga nisbati MorphoSys AG MOR|Kapitallashuvning balans qiymatiga nisbati nayabiosciences.com (NAYA)|Ascentage Pharma - Bozor kapitallashuvining balans qiymatiga nisbati